Publicacións en colaboración con investigadores/as de Hospital General Universitario de Valencia (12)

2023

  1. Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA)

    Epilepsy and Behavior, Vol. 145

2021

  1. Alzemon: estudio de seguimiento prospectivo del acetato de eslicarbacepina en monoterapia en pacientes con epilepsia de diagnóstico reciente

    Revista de neurologia, Vol. 72, Núm. 8, pp. 263-268

2019

  1. MONOZEB: Long-term observational study of eslicarbazepine acetate monotherapy

    Epilepsy and Behavior, Vol. 97, pp. 51-59

2018

  1. Perampanel in routine clinical use in idiopathic generalized epilepsy: The 12-month GENERAL study

    Epilepsia, Vol. 59, Núm. 9, pp. 1740-1752

2017

  1. Efficacy and safety of eslicarbazepine-acetate in elderly patients with focal epilepsy: Case series

    Seizure, Vol. 48, pp. 53-56

  2. Erratum to “Safety, efficacy and outcome-related factors of perampanel over 12months in a real-world setting: The FYDATA study” [Epilepsy Res. (2016) 126 (201–210)] (S0920121116301218)(10.1016/j.eplepsyres.2016.08.001)

    Epilepsy Research

2016

  1. Guía oficial de la Sociedad Española de Neurología de práctica clínica en epilepsia

    Neurologia, Vol. 31, Núm. 2, pp. 121-129

  2. NEOPLASM study: Real-life use of lacosamide in patients with brain tumor-related epilepsy

    Epilepsy and Behavior, Vol. 65, pp. 25-32

  3. Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: The FYDATA study

    Epilepsy Research, Vol. 126, pp. 201-210

2015

  1. Early Add-on Lacosamide in a Real-Life Setting: Results of the REALLY Study

    Clinical Drug Investigation, Vol. 35, Núm. 2, pp. 121-131

2014

  1. Factors influencing response to intravenous lacosamide in emergency situations: LACO-IV study

    Epilepsy and Behavior, Vol. 36, pp. 144-152

  2. Long-term safety and efficacy of eslicarbazepine acetate in patients with focal seizures: Results of the 1-year ESLIBASE retrospective study

    Epilepsy Research, Vol. 108, Núm. 7, pp. 1243-1252